FENC
Price
$5.94
Change
+$0.41 (+7.41%)
Updated
Apr 2 closing price
Capitalization
162.59M
35 days until earnings call
SCPX
Price
$0.14
Change
+$0.01 (+7.69%)
Updated
Apr 2 closing price
Capitalization
799.18K
Ad is loading...

FENC vs SCPX

Header iconFENC vs SCPX Comparison
Open Charts FENC vs SCPXBanner chart's image
Fennec Pharmaceuticals
Price$5.94
Change+$0.41 (+7.41%)
Volume$81.94K
Capitalization162.59M
SCORPIUS HOLDINGS
Price$0.14
Change+$0.01 (+7.69%)
Volume$187.76K
Capitalization799.18K
FENC vs SCPX Comparison Chart
Loading...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FENC vs. SCPX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FENC is a StrongBuy and SCPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (FENC: $5.94 vs. SCPX: $0.14)
Brand notoriety: FENC and SCPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FENC: 97% vs. SCPX: 18%
Market capitalization -- FENC: $162.59M vs. SCPX: $799.18K
FENC [@Biotechnology] is valued at $162.59M. SCPX’s [@Biotechnology] market capitalization is $799.18K. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FENC’s FA Score shows that 0 FA rating(s) are green whileSCPX’s FA Score has 1 green FA rating(s).

  • FENC’s FA Score: 0 green, 5 red.
  • SCPX’s FA Score: 1 green, 4 red.
According to our system of comparison, SCPX is a better buy in the long-term than FENC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FENC’s TA Score shows that 5 TA indicator(s) are bullish while SCPX’s TA Score has 5 bullish TA indicator(s).

  • FENC’s TA Score: 5 bullish, 5 bearish.
  • SCPX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SCPX is a better buy in the short-term than FENC.

Price Growth

FENC (@Biotechnology) experienced а -8.19% price change this week, while SCPX (@Biotechnology) price change was -12.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.26%. For the same industry, the average monthly price growth was -7.43%, and the average quarterly price growth was -11.99%.

Reported Earning Dates

FENC is expected to report earnings on May 08, 2025.

SCPX is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (-5.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FENC($163M) has a higher market cap than SCPX($799K). FENC YTD gains are higher at: -6.013 vs. SCPX (-58.182). FENC has higher annual earnings (EBITDA): 3.02M vs. SCPX (-22.84M). FENC has more cash in the bank: 40.3M vs. SCPX (4.81M). SCPX has less debt than FENC: SCPX (14.9M) vs FENC (32.1M). FENC has higher revenues than SCPX: FENC (49.3M) vs SCPX (10M).
FENCSCPXFENC / SCPX
Capitalization163M799K20,401%
EBITDA3.02M-22.84M-13%
Gain YTD-6.013-58.18210%
P/E Ratio64.14N/A-
Revenue49.3M10M493%
Total Cash40.3M4.81M838%
Total Debt32.1M14.9M215%
FUNDAMENTALS RATINGS
FENC vs SCPX: Fundamental Ratings
FENC
SCPX
OUTLOOK RATING
1..100
6754
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6096
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCPX's Valuation (8) in the Biotechnology industry is significantly better than the same rating for FENC (91). This means that SCPX’s stock grew significantly faster than FENC’s over the last 12 months.

SCPX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FENC (100). This means that SCPX’s stock grew similarly to FENC’s over the last 12 months.

SCPX's SMR Rating (98) in the Biotechnology industry is in the same range as FENC (100). This means that SCPX’s stock grew similarly to FENC’s over the last 12 months.

FENC's Price Growth Rating (60) in the Biotechnology industry is somewhat better than the same rating for SCPX (96). This means that FENC’s stock grew somewhat faster than SCPX’s over the last 12 months.

FENC's P/E Growth Rating (97) in the Biotechnology industry is in the same range as SCPX (100). This means that FENC’s stock grew similarly to SCPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FENCSCPX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
77%
Bullish Trend 14 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
FENC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OLVCX18.78N/A
N/A
JPMorgan Large Cap Value C
THORX38.30N/A
N/A
Thornburg Global Opportunities R3
RPGIX19.61N/A
N/A
T. Rowe Price Global Industrials
MMIUX11.07N/A
N/A
MassMutual Select TRP Intl Equity I
UIVQX11.64N/A
N/A
MFS Intrinsic Value R4

SCPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPX has been loosely correlated with SPRB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPX
1D Price
Change %
SCPX100%
+7.64%
SPRB - SCPX
43%
Loosely correlated
+9.21%
FENC - SCPX
39%
Loosely correlated
+7.41%
VRPX - SCPX
37%
Loosely correlated
-4.69%
OVID - SCPX
34%
Loosely correlated
+9.78%
BOLT - SCPX
33%
Loosely correlated
+4.70%
More